PRKAA2 and fatty liver disease: The reduction in FFA-induced hepatic steatosis in MKRN1-ablated HepG2 cells and the chronic AMPK activation in the livers of MKRN1-null mice led us to investigate the effect of MKRN1 deficiency on HFD-induced NAFLD.